Abstract:Serum amyloid A (SAA) is a highly conserved acute‐phase protein that plays roles in activating multiple pro‐inflammatory pathways during the acute inflammatory response and is commonly used as a biomarker of inflammation. It has been linked to beneficial roles in tissue repair through improved clearance of lipids and cholesterol from sites of damage. In patients with chronic inflammatory diseases, elevated levels of SAA may contribute to increased severity of the underlying condition. The majority of circulating SAA is bound to lipoproteins, primarily high‐density lipoprotein (HDL). Interaction with HDL not only stabilizes SAA but also alters its functional properties, likely through altered accessibility of protein–protein interaction sites on SAA. While high‐resolution structures for lipid‐free, or apo‐, forms of SAA have been reported, their relationship with the HDL‐bound form of the protein, and with other possible mechanisms of SAA binding to lipids, has not been established. Here, we have used multiple biophysical techniques, including SAXS, TEM, SEC‐MALS, native gel electrophoresis, glutaraldehyde crosslinking, and trypsin digestion to characterize the lipid‐free and lipid‐bound forms of SAA. The SAXS and TEM data show the presence of soluble octamers of SAA with structural similarity to the ring‐like structures reported for lipid‐free ApoA‐I. These SAA octamers represent a previously uncharacterized structure for lipid‐free SAA and are capable of scaffolding lipid nanodiscs with similar morphology to those formed by ApoA‐I. The SAA–lipid nanodiscs contain four SAA molecules and have similar exterior dimensions as the lipid‐free SAA octamer, suggesting that relatively few conformational rearrangements may be required to allow SAA interactions with lipid‐containing particles such as HDL. This study suggests a new model for SAA–lipid interactions and provides new insight into how SAA might stabilize protein‐lipid nanodiscs or even replace ApoA‐I as a scaffold for HDL particles during inflammation.

Serum amyloid A1: Structure, function and gene polymorphism

Emerging Functions of Serum Amyloid A in Inflammation

Adenoviral Expression of Murine Serum Amyloid A Proteins to Study Amyloid Fibrillogenesis

Expression of Mouse Acute-Phase (saa1.1) and Constitutive (saa4) Serum Amyloid A Isotypes - Influence on Lipoprotein Profiles

Serum Amyloid A1 (SAA1) Revisited: Restricted Leukocyte-Activating Properties of Homogeneous SAA1

Serum Amyloid A Exhibits Ph Dependent Antibacterial Action and Contributes to Host Defense Against Staphylococcus Aureus Cutaneous Infection.

Copy Number Variations in Serum Amyloid A Play a Role in the Determination of Its Individual Baseline Concentrations.

Expression of Mouse Apolipoprotein SAA1.1 in CE/J Mice: Isoform-Specific Effects on Amyloidogenesis

Acute phase reactant serum amyloid A in inflammation and other diseases.

Acute-serum amyloid A and A-SAA-derived peptides as formyl peptide receptor (FPR) 2 ligands

Structural studies of a serum amyloid A octamer that is primed to scaffold lipid nanodiscs

Amyloidogenesis. One serum amyloid A isotype is selectively removed from the circulation

SAA1 Gene Polymorphisms in Osteoporosis Patients

Serum amyloid protein A in inflammatory bowel disease: from bench to bedside

Serum Amyloid A Stimulates PKR Expression and HMGB1 Release Possibly through TLR4/RAGE Receptors

Inflammation-Dependent Cerebral Deposition of Serum Amyloid A Protein in A Mouse Model of Amyloidosis

Genetic polymorphisms of serum amyloid A1 and coronary artery disease risk.

High-Density Lipoproteins and Serum Amyloid A (SAA)

Relationship between gene polymorphism of serum amyloid A protein 1 and coronary heart disease

Serum Amyloid a Attenuates Tau Phosphorylation in a Systemic Inflammation Model